Clinical Trials Browser

Completed × folfirinox × Clear all

NCT03828799 2026-02-27

FOLFIRINOX-R

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms

NCT04469556 2026-02-20

PASS-01

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Metastatic

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03724994 2025-08-29

CHAMP

Gastrointestinal

Pancreatic Neoplasms

NCT03941093 2024-11-05

LAPIS

Phase 3 Completed

284 enrolled 14 charts

Gastrointestinal

Pancreatic Cancer Non-resectable

NCT01595321 2024-08-14

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Phase 2 Completed

19 enrolled 16 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02352337 2024-07-10

PANOPTIMOX

Phase 2 Completed

276 enrolled 12 charts

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT01827553 2024-04-11

CONKO-007

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT04431258 2024-03-18

PanC-ASAP

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02128100 2024-03-05

BCC-RAD-13

Phase 2 Completed

5 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03914170 2023-09-26

ESTER

Gastrointestinal

Colorectal Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Phase 2 Completed

229 enrolled 14 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT04990037 2023-06-29

CAPAFOUR

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT03504423 2023-01-03

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

Phase 3 Completed

528 enrolled 11 charts

Gastrointestinal

Pancreatic Cancer Metastatic

NCT02873598 2022-12-19

A Dose Escalation Trial of SBRT After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Phase 1 Completed

14 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02178709 2022-04-19

A Phase II Study of Neoadjuvant FOLFIRINOX

Phase 2 Completed

48 enrolled 16 charts

Neoplasms

NCT01485744 2020-08-04

LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01896869 2020-05-19

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Phase 2 Completed

83 enrolled 16 charts

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

NCT02456714 2020-03-10

4CC

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

NCT01661088 2019-11-13

A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients

Phase 2 Completed

25 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03590275 2018-07-18

HOPE

Gastrointestinal

Pancreatic Neoplasms

NCT01523457 2017-08-30

FOLFIRINOX

Phase 2 Completed

75 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01383538 2017-08-08

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01488552 2016-08-18

Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms